CORRECTED: Jefferson Gets Dibs On Patents From Cancer Doc's Research

Law360, Philadelphia (September 7, 2012, 2:27 PM EDT) -- A renowned cancer researcher, accused in August of stealing research belonging to his former employer Thomas Jefferson University, agreed to a temporary injunction Thursday giving the school first dibs on patent applications before he publishes any material connected with his work at the school.

During a conference with Philadelphia Court of Common Pleas Judge Gary Glazer, attorneys for researcher Michael Lisanti agreed to give Jefferson two weeks advance notice of any articles or public remarks in order to give the school an opportunity to submit any...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.